Article
Association of Prognostic Value of Primary Tumor Location in Stage III Colon Cancer With RAS and BRAF Mutational Status.
JAMA oncology - 12 Jul 2018
Taieb Julien, Kourie Hampig Raphael, Emile Jean-François, Le Malicot Karine, Balogoun Ralyath, Tabernero Josep, Mini Enrico, Folprecht Gunnar, Van Laethem Jean-Luc, Mulot Claire, Bouché Olivier, Aparicio Thomas, Michel Pierre, Thaler Josef, Bridgewater John, Van Cutsem Eric, Perkins Géraldine, Lepage Come, Salazar Ramon, Laurent-Puig Pierre
Abstract excerpt
Importance: We know of no data on the prognostic value of primary tumor location (PTL) according to BRAF, RAS, and microsatellite instability (MSI) status in patients who have undergone resection for colon cancer (CC) and have been treated with current standard adjuvant chemotherapy. Objective: To determine the prognostic and predictive value of PTL according to BRAF, RAS, and MSI status in patients with stage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
